Daily digest · Wed · 8 Apr 2026

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.

🔴🟠 HIGH PRIORITY (8+) — Best Finds by Topic

Novel Therapeutics

41946687 · Anti-PD-1 antibody penpulimab plus chemotherapy for R/M nasopharyngeal carcinoma: phase 3 RCT · 9/10 · Phase 3 RCT showing HR 0.45 for PFS in first-line NPC — potentially practice-changing

Cardiovascular-Metabolic

41946364 · Comparative efficacy of phase 2-3 therapies for non-cirrhotic MASH: network meta-analysis · 8/10 · Most comprehensive NMA of MASH therapies (64 trials, 12,787 pts) identifying FGF21 analogs and incretin multi-agonists as top performers

Hematologic Malignancies: No high-priority finds today (best candidate scored 7/10)

CBC/ML in Hematology: No high-priority finds today (best candidate scored 5/10)

Early Cancer Detection: No high-priority finds today (best candidate scored 6/10)

AI/ML in Clinical Diagnostics: No high-priority finds today (best candidate scored 6/10)

Precision Oncology: No high-priority finds today (best candidate scored 6/10)

Aging/Longevity: No high-priority finds today (best candidate scored 5/10)

Rare Diseases: No high-priority finds today (best candidate scored 5/10)

🟢⚪ STANDARD (4-7) — Top by Topic

Hematologic Malignancies

41946674 · Imetelstat cytopenias and clinical responses in lower-risk MDS · 7/10 · Treatment Innovation 41946709 · Ponatinib promotes CD8+ T stem cell memory and enhances CAR-T efficacy · 5/10 · Treatment Innovation 41945941 · PD-L1/kynurenine/vitamin D immunosuppression in AML · 5/10 · Genomics/Precision Medicine

Early Cancer Detection / AI-ML Diagnostics

41946158 · Deep learning-enhanced Raman spectroscopy for breast cancer detection (95% accuracy, n=732) · 6/10 · Early Detection 41946564 · CD103+ T cells as flow cytometry marker for solid tumor metastasis (99-100% specificity) · 6/10 · Diagnostics 41945762 · ML identification of progressive pulmonary fibrosis using blood parameters (AUC 0.842, n=10,687) · 5/10 · Diagnostics

Novel Therapeutics

41946178 · CABRAMET: Cabozantinib for RCC brain metastases — first prospective trial (ORR 61.5%) · 7/10 · Treatment Innovation 41946650 · Subcutaneous atezolizumab for NSCLC review · 5/10 · Treatment Innovation

Cardiovascular-Metabolic

41946303 · Canakinumab precision therapy in cardiovascular inflammation (review) · 4/10 · Treatment Innovation

Aging/Population Health

41946282 · Explainable ML for NPC burden in aging Asia · 4/10 · Public Health

Rare Diseases

41946032 · Temporal bone rhabdomyosarcoma in children — systematic review · 5/10 · Treatment Innovation

💡 UNSOLICITED FINDS

41946736 · Alpibectir-Ethionamide combination for TB (Nature Comms) · 6/10 · Phase 1 safety + preclinical bactericidal activity; novel approach to drug-resistant TB

📊 TODAY'S BREAKDOWN

By research category: Treatment Innovation (8), Diagnostics (3), Genomics/Precision Medicine (2), Early Detection (1), Drug Development (2), Public Health (1)
By evidence maturity: Potentially Practice-Changing (2), Validated (5), Exploratory (8)
By watchlist topic: Hematologic malignancies (3 kept), CBC/ML (1), Early detection (3), AI/ML diagnostics (3), Precision oncology (2), Novel therapeutics (5), Cardiovascular-metabolic (2), Aging (1), Rare diseases (1)
By source type: peer_reviewed 15 | preprint 0
Topics with zero 8+ articles this run: Hematologic malignancies, CBC/ML, Early cancer detection, AI/ML diagnostics, Precision oncology, Aging/longevity, Rare diseases

🔧 RUN NOTES

CBC/ML topic sparse again (only 2 candidates); consistent pattern over recent runs
Large candidate pools in cardiovascular-metabolic (110) and aging (314) required strict filtering
Sentinel scan capped at 10 from 978 results; alpibectir-TB study flagged as unsolicited find
No window expansion triggered; no truncation issues; no partial failures